It is important to note that a team-based approach with urologists, radiation oncologists, radiologists, medical oncologists, and pathologists, along with multiple imaging modalities including PSMA PET/CT and MRI, and biopsy plus laboratory data, are required to make a proper diagnosis and stage prostate cancer. This evidence concerns the gene FOLH1 and prostate carcinoma.